<bill session="115" type="h" number="3536" updated="2019-04-18T16:14:08Z">
  <state datetime="2017-07-28">REFERRED</state>
  <status>
    <introduced datetime="2017-07-28"/>
  </status>
  <introduced datetime="2017-07-28"/>
  <titles>
    <title type="official" as="introduced">To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
    <title type="display">To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
  </titles>
  <sponsor bioguide_id="D000191"/>
  <cosponsors>
    <cosponsor bioguide_id="C000714" joined="2017-09-05"/>
    <cosponsor bioguide_id="C000984" joined="2017-09-05"/>
    <cosponsor bioguide_id="G000551" joined="2017-09-07"/>
    <cosponsor bioguide_id="K000009" joined="2017-09-05"/>
    <cosponsor bioguide_id="K000389" joined="2018-07-11"/>
    <cosponsor bioguide_id="S001145" joined="2017-09-05"/>
    <cosponsor bioguide_id="S000480" joined="2017-11-08"/>
  </cosponsors>
  <actions>
    <action datetime="2017-07-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-07-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-08-04">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="identical" number="1681"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Inflation and prices"/>
    <term name="Intellectual property"/>
    <term name="Medical research"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2017-07-28T04:00:00Z" status="Introduced in House">This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.</summary>
  <committee-reports/>
</bill>
